9 Result(s)
within
Edmund Chiong
Oncology
-
Article
Open AccessCardiovascular disease risk assessment and multidisciplinary care in prostate cancer treatment with ADT: recommendations from the APMA PCCV expert network
Androgen deprivation therapy (ADT) is the mainstay approach for prostate cancer (PCa) management. However, the most commonly used ADT modality, gonadotropin-releasing hormone (GnRH) agonists, has been associat...
-
Article
Utility of serum biomarkers for predicting cancer in patients with previous negative prostate biopsy
To review the role of serum biomarkers: prostate-specific antigen (PSA), PSA density (PSAD), free:total PSA ratio, prostate health index (PHI) and PHI density (PHID), along with magnetic resonance imaging (MRI...
-
Reference Work Entry In depth
Clinical Aspects and Investigations in Genitourinary Cancer
Genitourinary cancer is an important topic in the current era. Understanding the disease is important to tailor the treatment for individual patients. Clinical aspects and investigations are part and parcel in...
-
Living Reference Work Entry In depth
Clinical Aspects and Investigations in Genitourinary Cancer
Genitourinary cancer is an important topic in the current era. Understanding the disease is important to tailor the treatment for individual patients. Clinical aspects and investigations are part and parcel in...
-
Article
Open AccessErratum to: Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring
-
Article
Open AccessQuantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring
The use of radiolabeled choline as a positron emission tomography (PET) agent for imaging primary tumors in the prostate has been evaluated extensively over the past two decades. There are, however, conflictin...
-
Chapter
Renal Cancer
As the global incidence and mortality of kidney cancer increases, the treatment modalities of renal-cell carcinoma have also progressed over the last decade. There are improved surgical techniques, which aim t...
-
Article
New therapies for non-muscle-invasive bladder cancer
The treatment of non-muscle-invasive bladder cancer (NMIBC) remains a challenge owing to its increased tendency to recur and the possibility of progression to potentially dangerous muscle-invasive disease. Tre...
-
Article
Urinary markers in screening patients with hematuria
Hematuria is a common presenting symptom of urothelial malignancy. Although conventional urine analysis is very sensitive in detecting the presence of hematuria, it is not specific in detecting bladder cancer ...
